Uptake | |||||
Transduced xenograft | Ligand | % dose/cm3 | Ratio of transduced to WT | Ratio of transduced to muscle | References |
SKOV3 | 111In-DTPA-octreotide | 32 (4 h)*† | 38 (4 h)*† | 30 (4 h) | Rogers et al. (14) |
A-427 | 99mTc-P829 | 2.5 (5 h)*† | 4 (3 h)*† | 4 (3 h) | Zinn et al. (16) |
188Re-P829 | 2.2 (5 h)*† | ||||
SKOV3 | 99mTc-P2045 | 4.0 (2 h)*† | 12.2 (5 h)*† | ND | Chaudhuri et al. (38) |
A-427 | 94mTc-demotate 1 | >5 (2 h)*‡ | 10 (1 h), 20(2 h) | Rogers et al. (17) | |
HT1080 | 111In-DTPA-octreotide | 1.7 (24 h)*† | 14 (24 h)*† | 42 (24 h) | Yang et al. (39) |
MDA-MB-435 | 111In-DTPA-octreotide | 1.8 (24 h)*† | 18 (24 h) *† | 27 (24 h) | Singh et al. (40) |
C6 | 68Ga-DOTATOC | 15 (2 h)*‡ | 64 (2 h)*‡ | ∼500 (2 h) | Current work |